| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner
2 companies
Samaha Eli is a 10% Owner at Theravance Biopharma, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $162.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | STGW Stagwell Inc | Director | Buy | 665,757 | $4.33 | $2,881,182.39 | +4.4% | +32.2% | - | |
| May 9, 2025 | STGW Stagwell Inc | Director | Buy | 200,903 | $4.76 | $956,318.37 | +2.8% | +15.6% | - | |
| Aug 7, 2024 | TBPH Theravance Biopharma, Inc. | 10% Owner | Buy | 999,800 | $7.80 | $7,798,440.00 | +11.7% | +5.6% | +43.2% | |
| May 1, 2024 | TBPH Theravance Biopharma, Inc. | 10% Owner | Buy | 1,499,124 | $8.75 | $13,117,335.00 | +10.0% | +13.8% | +17.5% | |
| Mar 10, 2023 | STGW Stagwell Inc | Director | Buy | 750,000 | $6.75 | $5,062,500.00 | +11.7% | +17.6% | -15.9% | |
| May 12, 2022 | STGW Stagwell Inc | Director | Buy | 644,452 | $6.90 | $4,449,438.01 | +3.6% | -10.4% | -19.5% | |
| Dec 6, 2021 | STGW Stagwell Inc | Director | Buy | 292,961 | $8.14 | $2,383,929.69 | +2.7% | -10.8% | -11.8% | |
| Dec 2, 2021 | STGW Stagwell Inc | Director | Buy | 450,000 | $7.65 | $3,444,180.00 | +2.9% | -2.2% | -3.7% |